Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
256. |
ECCT/20/06/08 | E-MOTIVE TRIAL Early detection of PPH and treatment using the WHO MOTIVE ‘first response’ bundle: a cluster randomised trial with health economic analysis and mixed-methods evaluation. |
Principal Investigator(s) 1. Zahida Qureshi Site(s) in Kenya 1. Mwingi Sub county (level 4 ) hospital (Kitui county) 2. Nyeri Level 5 Hospital (Nyeri county) 3. Garissa county referral hospital (Garissa county) 4. Embu Level 5 hospital (Embu county) 5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county) 6. Meru Teaching and Referral Hospital (Meru county) 7. Kitengela Sub county Hospital (Kajiado county) 8. Kakamega County Government Referral Hospital (Kakamega county) 9. Mbagathi County Hospital (Nairobi City county) 10. St. Mary\'s Mission Hospital (Nairobi City county) |
View |
257. |
ECCT/20/03/01 | GlycoShig3 A Phase 2a age descending study to investigate the safety and immunogenicity of the SF2a-TT15 synthetic carbohydrate-based conjugate vaccine against Shigella flexneri 2a in adult, children and infant target population in endemic countries. |
Principal Investigator(s) 1. Fredrick Kipyegon Sawe Site(s) in Kenya Kenya Medical Research Institute Walter Reed Project Kericho |
View |
258. |
ECCT/20/06/01 | IAVI C100 Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults |
Principal Investigator(s) 1. Prof Walter Jaoko Godfrey Jaoko Site(s) in Kenya 1. KAVI-Insitute of Clinical Research, KNH site (Nairobi City county) |
View |
259. |
ECCT/20/02/03 | LNG 1.5mg for pericoital use A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg |
Principal Investigator(s) 1. Anne Mwihaki Macharia Site(s) in Kenya 1. Nairobi County (Nairobi City county) 2. Kiambu County (Kiambu county) |
View |
260. |
ECCT/22/03/05 | CHAPATI CHildren treated with vincristine: A trial regarding Pharmacokinetics, DNA And Toxicity of targeted therapy In pediatric oncology patients. |
Principal Investigator(s) 1. FESTUS MUIGAI NJUGUNA Site(s) in Kenya Moi Teaching and Referral Hospital |
View |